hrcak mascot   Srce   HID

Periodicum biologorum, Vol.118 No.2 Lipanj 2016.

Kratko priopćenje
https://doi.org/10.18054/pb.2016.118.2.3722

Maternal and umbilical homocysteine in preeclampsia

Mirna Vuković Bobić ; Kaiser Franz Josef Hospital, SMZ-Süd, Department of Obstetrics and Gynecology, Vienna, Austria
Jasna Čerkez Habek ; Department of Cardiology, Clinical Department of Internal Diseases, Sveti Duh University Hospital, Croatian Catholic University, Zagreb, Croatia
Dubravko Habek ; Clinical Department of Obstetrics and Gynecology, Sveti Duh University Hospital, Croatian Catholic University, Zagreb, Croatia

Puni tekst: engleski, pdf (299 KB) str. 117-122 preuzimanja: 283* citiraj
APA 6th Edition
Vuković Bobić, M., Čerkez Habek, J. i Habek, D. (2016). Maternal and umbilical homocysteine in preeclampsia. Periodicum biologorum, 118 (2), 117-122. https://doi.org/10.18054/pb.2016.118.2.3722
MLA 8th Edition
Vuković Bobić, Mirna, et al. "Maternal and umbilical homocysteine in preeclampsia." Periodicum biologorum, vol. 118, br. 2, 2016, str. 117-122. https://doi.org/10.18054/pb.2016.118.2.3722. Citirano 16.12.2018.
Chicago 17th Edition
Vuković Bobić, Mirna, Jasna Čerkez Habek i Dubravko Habek. "Maternal and umbilical homocysteine in preeclampsia." Periodicum biologorum 118, br. 2 (2016): 117-122. https://doi.org/10.18054/pb.2016.118.2.3722
Harvard
Vuković Bobić, M., Čerkez Habek, J., i Habek, D. (2016). 'Maternal and umbilical homocysteine in preeclampsia', Periodicum biologorum, 118(2), str. 117-122. doi: https://doi.org/10.18054/pb.2016.118.2.3722
Vancouver
Vuković Bobić M, Čerkez Habek J, Habek D. Maternal and umbilical homocysteine in preeclampsia. Periodicum biologorum [Internet]. 2016 [pristupljeno 16.12.2018.];118(2):117-122. doi: https://doi.org/10.18054/pb.2016.118.2.3722
IEEE
M. Vuković Bobić, J. Čerkez Habek i D. Habek, "Maternal and umbilical homocysteine in preeclampsia", Periodicum biologorum, vol.118, br. 2, str. 117-122, 2016. [Online]. doi: https://doi.org/10.18054/pb.2016.118.2.3722

Sažetak
Background and purpose: Were to assess the association between homocysteine levels and development of preeclampsia, to determine homocysteine levels in fetal circulation, to differentiate homocysteine levels in mild and severe preeclampsia and to compare homocysteine levels in pregnant women with preeclampsia with homocysteine levels measured in the same group of women six months after delivery.

Material and methods: The study included 55 pregnant women with mild or severe preeclampsia (hypertensia with proteinuria), while control group of 50 healthy pregnant women. Maternal and umbilical blood homocysteine levels were determined by the fluorescence polarization immunoassay. Shapiro-Wilks, Mann-Whitney and Wilcoxon statistical tests performed for statistical analysis.

Results: In women with preeclampsia, the mean homocysteine level was by 0.744 μmol/L higher than in control women; with mild preeclampsia, the level was by 2.752 μmol/L lower as compared to the women with severe preeclampsia (p < 0.0001). In women with preeclampsia, the mean umbilical blood homocysteine level was by 0.268 μmol/L lower than the respective level measured in control group (p < 0,0001). In women with preeclampsia, the mean homocysteine level was by 0.878 μmol/L lower in the same group of women six months after delivery (p < 0.0001).

Conclusion: Homocysteine are lower in preeclamptic women six months after delivery.
The neonates born to mothers with preeclampsia are not at a higher exposure to homocysteine.

Ključne riječi
preeclampsia; homocysteine; maternal blood; umbilical blood

Hrčak ID: 162224

URI
https://hrcak.srce.hr/162224

Posjeta: 399 *